44.222.134.250
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-
Home NORD: Giant Cell (Session 2)

Continuing Medical Education

NORD: Giant Cell (Session 2)

Read More
By rd360stg
NORD: Giant Cell (Session 1)
By rd360stg
Optimizing Primary Care for Patients with Rare Disease
By rd360stg
NORD: Spinal Muscular Atrophy
By rd360stg
NORD: Pediatric Epilepsy
-Advertisement-
-Advertisement-
-Advertisement=-
By rd360stg
Prosthetic Joint Infection Drug Granted Orphan Drug Designation
By rd360stg
ProQR Receives Rare Pediatric Disease Designation from FDA for QR-421a
By rd360stg
FDA Authorizes Phase 1/2 Clinical Trial for INO-3107 for Rare Recurrent Respiratory Papillomatosis
By rd360stg
Orphan Drug Status Granted to Investigational Systemic Sclerosis Treatment
-Advertisement-
-Advertisement-
-Advertisement=-
By rd360stg
FDA Approves First Treatment for Thyroid Eye Disease
By rd360stg
Investigational Therapy Granted Orphan-Drug Designation for the Investigational Treatment of Systemic Sclerosis
By rd360stg
Investigational Therapy Granted Orphan-Drug Designation for the Investigational Treatment of Systemic Sclerosis
-Advertisement-
-Advertisement-
-Advertisement-

Contact

Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809

+908-505-8899
[email protected]

Social Links

© 2024 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved
-Advertisement-
-Advertisement-